MS Patient Dies After Starting Novartis Drug, Gilenya


Novartis AG, manufacturer of the drug, Gilenya (fingolimod), confirmed this week that a 59 year old patient suffering from multiple sclerosis passed away after beginning treatment with the drug, the first of its kind to be approved by the FDA to treat the neurological disease. Novartis noted that this is the first reported death to [...]